Lung Diseases Clinical Trial
Official title:
Cardiac Function in Swimming-Induced Pulmonary Edema (SIPE) - a Case Control Study
Verified date | January 2024 |
Source | Dalarna County Council, Sweden |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Acute or chronic cardiac dysfunction could be a contributing factor to swimming-induced pulmonary edema (SIPE). Knowledge on cardiac function in SIPE is limited and recommendations for cardiac evaluation of patients with SIPE are lacking. The present study was designed to assess cardiac function in patients with SIPE and in asymptomatic swimmers.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | December 2026 |
Est. primary completion date | December 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: for patients: - respiratory symptoms during or after swimming at the Vansbrosimningen open water swimming event - diagnosis SIPE by signs of pulmonary edema on lung ultrasound - peripheral oxygen saturation =95% for controls: - completion of a swimming race of the Vansbrosimningen open water swimming event. - no respiratory symptoms during or after swimming - no signs of pulmonary edema on lung ultrasound - matched to patients with SIPE regarding sex and age Exclusion criteria: - declined consent - hemodynamic instability or decreased consciousness |
Country | Name | City | State |
---|---|---|---|
Sweden | Center of Clinical Research Dalarna | Falun |
Lead Sponsor | Collaborator |
---|---|
Dalarna County Council, Sweden |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Acute Echocardiography | Transthoracic echocardiography with parasternal, apical and subcostal views. Including measurement of ventricular wall size, left ventricular strain, ejection fraction according to the modified Simpson method, diastolic function (using tissue doppler, mitral flow and pulmonary vein flow), right ventricular tricuspid annular plane systolic excursion (TAPSE), pressure gradient over the tricuspid valve, assessment of valve dysfunction, size and respiratory variation of the inferior vena cava, assessment of pericardial fluid. | within 4 hours after termination of swimming | |
Primary | Acute Electrocardiogram (ECG) - Rytm analysis | 12-lead electrocardiogram (ECG). Rytm analysis and frequency (beats per minute) | within 4 hours after termination of swimming | |
Primary | Acute Electrocardiogram (ECG) - Heart axis | 12-lead electrocardiogram (ECG). Assessment of QRS-axis (degrees) | within 4 hours after termination of swimming | |
Primary | Acute Electrocardiogram (ECG) - Amplitudes and intervals | 12-lead electrocardiogram (ECG). Duration of PQ-interval (ms), QRS-complex (ms), QT-interval (ms), QRS amplitude (mV) | within 4 hours after termination of swimming | |
Primary | Acute Electrocardiogram (ECG) - Signs of myocardial ischemia | 12-lead electrocardiogram (ECG). ST-elevation, ST-depression, T-wave inversion, Q wave. | within 4 hours after termination of swimming | |
Primary | Acute cardiac biomarkers - Troponin I | Venous samples. Measurement of hs-Troponin I (ng/L). | 4-6 hours after termination of swimming | |
Primary | Acute cardiac biomarkers - NT-pro-BNP | Venous samples. Measurement of NT-pro-BNP (ng/L) | 4-6 hours after termination of swimming | |
Secondary | Baseline Echocardiography | Transthoracic echocardiography with parasternal, apical and subcostal views. Examination at rest. Including measurement of ventricular wall size, left ventricular strain, ejection fraction according to the modified Simpson method, diastolic function (using tissue doppler, mitral flow and pulmonary vein flow), right ventricular tricuspid annular plane systolic excursion (TAPSE), pressure gradient over the tricuspid valve, assessment of valve dysfunction, size and respiratory variation of the inferior vena cava, assessment of pericardial fluid. | within 12 months after swimming | |
Secondary | Baseline Electrocardiogram (ECG) - Rytm analysis | 12-lead Electrocardiogram (ECG). Examination at rest. Rytm analysis and frequency (beats per minute) | within 12 months after swimming | |
Secondary | Baseline Electrocardiogram (ECG)- Heart axis | 12-lead Electrocardiogram (ECG). Examination at rest. Assessment of QRS-axis (degrees) | within 12 months after swimming | |
Secondary | Baseline Electrocardiogram (ECG) - Amplitudes and intervals | 12-lead Electrocardiogram (ECG). Examination at rest. Duration of PQ-interval (ms), QRS-complex (ms), QT-interval (ms), QRS amplitude (mV) | within 12 months after swimming | |
Secondary | Baseline Electrocardiogram (ECG) - Signs of myocardial ischemia | 12-lead Electrocardiogram (ECG). Examination at rest. ST-elevation, ST-depression, T-wave inversion, Q wave. | within 12 months after swimming | |
Secondary | Baseline cardiac biomarkers - Troponin I | Venous samples. Measurement of hs-Troponin I (ng/L). Examination at rest | within 12 months after swimming | |
Secondary | Baseline cardiac biomarkers - NT-pro-BNP | Venous samples. Measurement of NT-pro-BNP (ng/L). Examination at rest | within 12 months after swimming |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A |